You are here

Tanezumab and Nerve Function In Arthritis Patients

Last updated on March 14, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Osteoarthritis
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- BMI less or equal to 39 kg/m2

- Osteoarthritis (arthritis) of the knee or hip with pain score that qualifies

- Willing to comply with study visit schedule and study requirements, including, for
women of child-bearing potential or male patients with female partners of
child-bearing potential, the use of 2 forms of birth control, one of which is a
barrier method.

- Patients must consent in writing to participate in the study.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Untreated, uncontrolled diseases,

- Unwilling or unable to discontinue the use of prohibited medications, including other
pain medications, during the screening period and during the study,

- Significant cardiac disease within the past 6 months

- Significant neurological disease (e.g. peripheral neuropathy, multiple sclerosis,
stroke) or signs of neuropathy at screening

- Known bleeding disorder or anticoagulation therapy

- Planned surgery during the study period

- History of alcoholism or drug abuse in the past 2 years

- Unable to use acetaminophen

- Use of a biologic (including live vaccines, with the exception of Flumist) within the
past 3 months

- Allergic reaction to a biologic or an antibody in the past

- Disqualifying laboratory values, including Hepatitis B or C, HIV or drug test

- Cancer in the past 5 years. Basal cell or squamous cell carcinoma are okay.

- Medical condition that may interfere with study endpoints or safety of the subject as
determined by the investigator.

NCT00863772
Pfizer
Terminated
Tanezumab and Nerve Function In Arthritis Patients

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

Based on your search, you may also be interested in

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now